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Abstract
Objectives—This study sought to investigate, in-vitro, the effects of a recently developed triple 
antibiotic paste (TAP)-mimic polymer nanofibrous scaffold against Porphyromonas gingivalis 
(Pg)-infected dentin biofilm.
Materials and Methods—Dentin specimens (4×4×1mm3) were prepared from human canines. 
The specimens were sterilized, inoculated with Pg (ATCC 33277), and incubated for one week to 
allow for biofilm formation. Infected dentin specimens were exposed for 3 days to the following 
treatments: antibiotic-free polydioxanone scaffold (PDS, control), PDS+25wt.%TAP (25 mg of 
each antibiotic [metronidazole, ciprofloxacin, and minocycline] per mL of the PDS polymer 
solution), or a saturated TAP-based solution (50 mg of each antibiotic per mL of saline solution). 
In order to serve as the negative control, infected dentin specimens were left untreated (bacteria 
only). To determine the antimicrobial efficacy of the TAP-mimic scaffold, a colony-forming unit 
(CFU/mL) (n=10/group) measurement was performed. Furthermore, additional specimens (n=2/
group) were prepared to qualitatively study biofilm inhibition via scanning electron microscopy 
(SEM). Statistics were performed and significance was set at the 5% level.
Results—Both the TAP-mimic scaffold and the positive control (TAP solution) led to complete 
bacterial elimination, differing statistically (p<0.05) from the negative control group (bacteria 
only). No statistical differences were observed for CFU/mL data between antibiotic-free scaffolds 
(2.7 log10 CFU/mL) and the negative control (5.9 log10 CFU/mL).
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Conclusions—The obtained data revealed significant antimicrobial properties of the novel PDS-
based TAP-mimic scaffold against an established Pg-infected dentin biofilm.
Clinical relevance—Collectively, the data suggest that the proposed nanofibrous scaffold might 
be used as an alternative to the advocated clinical gold standard (i.e., TAP) for intracanal 
disinfection prior to regenerative endodontics.
Keywords
Electrospinning; Scaffold; Antibiotic; Disinfection; Endodontics; Nanofibers
Introduction
Porphyromonas gingivalis is a Gram-negative, strictly anaerobic bacterium. It is commonly 
found in association with primary endodontic infections and/or periapical pathology [1-4]. 
Traditional endodontic treatment using antimicrobial substances, mechanical 
instrumentation, and obturation has demonstrated to be effective against most P. gingivalis-
associated infections [5]. Even so, depending on the time and persistence of bacterial 
colonization, they can organize themselves into complex biofilms, mainly in the apical area. 
Indeed, recent findings have shown that P. gingivalis may also be related to the colonization 
of traumatized immature permanent teeth with pulpal necrosis [6].
Over the past decade, the clinical management of immature permanent necrotic teeth has 
changed considerably when compared to the conventional apexification treatment. In these 
cases, infection has been increasingly treated with pulp revascularization protocols using 
antimicrobial agents, including but not limited to irrigant solutions and calcium hydroxide 
[7-9]. Calcium hydroxide, though traditionally accepted as an intracanal medication, may 
present antimicrobial limitations against some resistant species or microbial biofilms [10]. In 
this way, for regenerative/revascularization purposes, the “gold-standard” triple antibiotic 
paste (TAP) (i.e., ciprofloxacin/CIP, metronidazole/MET, and minocycline/MINO) has been 
used [11-13]. Regrettably, this antibiotic paste makes use of substantial amounts (1 g/mL) of 
the aforementioned antibiotics, which have been linked with toxic effects to stem cells key 
to the regenerative process [14]. In recent years, an innovative strategy has been considered 
to develop a low-concentration, yet antimicrobially-effective and biocompatible polymer-
based nanofibrous electrospun scaffolds as a drug delivery system to promote intracanal 
biofilm eradication without jeopardizing stem cell viability and function [15,16]. 
Electrospinning has been considered as a highly effective process to obtain extracellular 
matrix (ECM)-mimicking structures with adequate chemistry and three-dimensional porous 
architectures [11, 15]. Moreover, it has enabled the synthesis of bioactive (i.e., therapeutic 
drugs and growth factors) polymer-based nanofibrous scaffolds [11, 15-19]. Thus, the 
purpose of this in-vitro study was to investigate the effects of a recently developed 
antibiotic-containing TAP-mimic scaffold against an established P. gingivalis-infected dentin 
biofilm.
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Materials and methods
Processing of a TAP-mimic Polymer-based Scaffold
Polydioxanone (PDS II®, Ethicon, Somerville, NJ, USA) suture was selected as the scaffold 
polymer. In brief, violet-colored PDS sutures were cut (ca. 2-3 cm) and incubated in 
dichloromethane (Sigma-Aldrich, St. Louis, MO, USA) at room temperature (RT) for 2 days 
to remove the dye [15-19]. Next, clear PDS pieces were dissolved in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFP, Sigma-Aldrich). Metronidazole, ciprofloxacin, and 
minocycline (Sigma-Aldrich) were added to the polymer solution at a concentration of 25 
mg/mL relative to the total PDS [600 mg] weight (i.e., 150 mg of each antibiotic) and mixed 
together under stirring to obtain the TAP-mimic scaffold (i.e., PDS+25wt.%TAP). Pure PDS 
(control) and TAP-mimic polymer solutions were spun into scaffolds using a custom-made 
electrospinning system. The polymer solutions were then loaded into distinct 5-mL plastic 
syringes (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) fitted with a metallic 
27-gauge blunt-tip needle and placed in a syringe pump (Legato 200, KD Scientific Inc., 
Holliston, MA, USA) to be dispensed at a rate of 2 ml/h. The fibers were collected at RT on 
an aluminum foil-covered rotating (120 revolutions per minute, rpm), grounded stainless 
steel drum (φ = 4 cm) placed 18 cm away from the needle tip. During electrospinning, 
electrical voltage between 15-19 kV was applied to the needle using a high voltage power 
supply (ES50P-10W/DAM, Gamma High-Voltage Research, Inc., Ormond Beach, FL, 
USA). After electrospinning, the scaffolds were removed from the mandrel and placed under 
vacuum at RT for 48 h to ensure complete elimination of any residual solvent prior to 
storage at 4°C [15-19].
Antimicrobial Evaluation of P. gingivalis Biofilm-infected Dentin Specimens
This study was approved (protocol #1407656657) by the local Institutional Review Board 
(Indiana University). Twenty-four recently extracted, caries-free, non-restored human canine 
teeth were cleansed and stored in 0.1% thymol until used [18,19]. The crowns were 
sectioned using a diamond disc. Next, the teeth were cut along the bucco-lingual plane to 
obtain two halves for dentin specimen (4×4×1 mm3) preparation [19]. The cementum was 
removed and the specimens were wet-finished with SiC papers (600-1200-grit). The 
specimens were soaked in 2.5% NaOCl and 17% ethylenediamine tetraacetic acid (EDTA, 
Inter-Med, Inc., Racine, WI, USA) solutions for 3 min each in an ultrasonic bath (L&R 2014 
Ultrasonic Cleaning System, L&R Manufacturing Company, Keamy, NJ, USA) to remove 
the smear layer, rinsed in saline solution for 10 min, and then autoclaved (121°C for 20 min) 
[18,19]. Next, the specimens were aseptically placed in sterile 24-well plates (Costar, 
Corning Life Sciences, Tewksbury, MA, USA) with the dentin side positioned upwards. A 
200-μL Pg (ATCC 33277) bacterial suspension (ca. 106 bacteria) containing 1.8 mL of Brain 
Heart Infusion media supplemented with 5% (v/v) Vitamin K and Hemin (BHI, Difco 
Laboratories Inc., Detroit, MI, USA) was added to each well. The plates were incubated in 
anaerobic jars (37°C) for 7 days to allow for biofilm formation. The broth was changed 
every two days. All the specimens were rinsed for 1 min (2×) in PBS (Sigma-Aldrich) to 
remove non-adherent bacterial cells prior to treatment. Infected dentin specimens (n=12/
group) were randomly divided into four groups: pure PDS (antibiotic-free scaffold), TAP-
mimic scaffolds (weight=12.32±0.92 mg, which accounts for ca. 3.1 mg of the antibiotics), 
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TAP solution (50 mg/mL of each of the antibiotics), and one negative control (7-days 
biofilm untreated). The scaffolds (15×15 mm2) were sterilized by UV-irradiation [15,17-19], 
adapted to plastic inserts (CellCrown,™ Scaffdex Ltd, Tampere, Finland), and then placed in 
wells containing the infected dentin specimens immersed in 1 mL of PBS [18,19]. For the 
TAP and negative control groups, the specimens were immersed in 1 mL of TAP and saline 
solution, respectively. The plates were incubated in anaerobic jars at 37°C for 3 days. The 
specimens were then prepared for biofilm assay (CFU/mL) by gently washing twice in PBS, 
followed by placement into vials containing 2 mL of PBS. The samples were sonicated for 
10 s (Vibra Cell; Sonics & Materials, Inc., Newtown, CT, USA) and vortexed for 30 s [15, 
18-19]. Then a 10-fold serial dilution was prepared (10−1–10−4) in PBS in which 100 μL of 
dislodged P. gingivalis biofilm solution was spread onto blood agar plates (Fisher Scientific, 
Pittsburgh, PA, USA). The plates were incubated in anaerobic jars at 37°C for 5 days before 
the colonies were counted. Scanning electron microscopy (SEM, JSM-5310LV, JEOL, 
Tokyo, Japan) was carried out (n=2/group) to qualitatively assess biofilm inhibition. In 
detail, the dentin specimens were harvested, rinsed with PBS to remove unbound bacteria, 
and fixed in buffered 2.5% glutaraldehyde (Sigma-Aldrich). Prior to SEM imaging, the 
specimens were dehydrated in an ascending ethanol series, mounted on Al stubs, and 
sputter-coated with Au-Pd [18,19].
Statistical Analysis
CFU/mL results were analyzed using the Kruskal-Wallis test, followed by multiple pair-wise 
group comparisons using the Dunn test (P < 0.05).
Results
Figure 1 shows the bacterial counts (log10 CFU/mL) after 3 days of dentin biofilm exposure 
to the distinct scaffolds. The highest bacterial counts (5.9 log10 CFU/mL) were associated 
with dentin specimens exposed to the pure PDS scaffolds. Meanwhile, the 25 wt.% TAP-
mimic polymer scaffold and the positive control (i.e., TAP solution) led to complete 
bacterial elimination, differing statistically (p<0.05) from the negative control (bacteria 
only). No statistical differences were observed for CFU/mL data between antibiotic-free 
PDS-based polymer scaffolds (2.7 log10 CFU/mL) and the negative control (5.9 log10 CFU/
mL).
SEM images revealed a significant amount of bacteria-forming microbial biofilms after 7 
days of P. gingivalis inoculation (Figure 2). Dentin specimens exposed to antibiotic-free 
PDS scaffolds demonstrated the presence of viable bacteria on the surface (Figure 3A), 
agreeing with the CFU/mL findings. SEM images indicated that both the TAP-solution 
treated and 25 wt.%TAP-mimic scaffold were able to eradicate most of the viable bacteria 
without removing them from the dentin surface (Figure 2). The bacteria were not considered 
viable due to the observation of irregularities and porosities in their membrane surfaces 
(Figures 3B and 3C). Furthermore, the SEM images also revealed the formation of small, 
insoluble agglomerates over the dentin surface (Figure 3C) after treatment with the TAP 
solution.
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Discussion
This study demonstrated the antimicrobial clinical potential of a recently proposed TAP-
mimic antibiotic delivery system [19] against strictly anaerobic bacteria (P. gingivalis). 
Predicting the long-term success of endodontic treatment is mainly dependent on the 
achievement of a bacteria-free environment [20]. However, root canal disinfection still 
represents a challenge due to the complex anatomy of the root canals and/or the non-optimal 
chemical substances usually used during treatment (e.g., irrigant solutions and intracanal 
medicaments) [21,22]. Literature has proven that failure of canal disinfection frequently 
occurs when microbial biofilms are present inside or outside the root canal [23,24]. In 
contrast to the conventional treatment (i.e., apexification), regenerative endodontics involves 
not only root canal disinfection, but also the association between bacterial elimination and 
development of a “pulp-like” tissue containing differentiated odontoblasts, in which the 
dentin walls increase in thickness and length, resulting in proper root maturation [11].
P. gingivalis is a virulent pathogen usually related to primary endodontic infection and is 
found in clinical cases of apical periodontitis [25]. In the present study, this bacterium was 
chosen, based on the occurrence of this pathogen in cases of traumatized necrotic immature 
permanent teeth [26]. This investigation succeeded in effectively developing and eliminating 
a 7-day-old P. gingivalis biofilm, despite the difficulties related to handling with strictly 
anaerobic species. The CFU/mL counting and SEM images in the control group 
demonstrated the viability of the bacteria and the presence of P. gingivalis biofilm on both 
the dentin surface and inside the dentinal tubules (Figure 2). Nonetheless, it is not possible 
to quantify bacteria viability and the effectiveness of medicaments inside dentinal tubules 
through a colony-counting assay. To evaluate the ingrowth of biofilm into dentinal tubules 
requires the use of confocal laser scanning microscopy (CLSM). Currently, P. gingivalis 
presents survival restrictions that make it difficult to be assessed using the aforementioned 
technique.
The two foremost treatment strategies employed in the cases of necrotic immature teeth are 
apexification (i.e., calcium hydroxide) or revascularization/regeneration (i.e., TAP as the 
intracanal medicament) [26,27]. Most importantly, over the past decade, pulp 
revascularization has become a very popular approach, especially when considering the 
success demonstrated in several clinical cases/serial reports that highlighted healing of 
periapical lesions associated with complete root development provided by the ingrowth of a 
“pulp-like” tissue [28]. Conversely, the success of regenerative endodontic treatments is very 
much dependent on the achievement and maintenance of a bacteria-free niche, lately attained 
through the use of the so-called TAP [26, 29-31]. Regrettably, the TAP has been used in a 
very high concentration (1 g/mL), which has led to tooth discoloration and cell death 
[14,32]. Of note, antibiotic-containing nanofibrous-based polymer scaffolds have 
demonstrated great clinical potential in terms of releasing a low-concentration, yet 
antimicrobially-effective dose of antibiotics through an initial burst (first 24 h), while 
sustaining its effects for up to 14 days [16,17,19]. Remarkably, the proposed antibiotic 
release mechanism may avoid root canal reinfection and residual bacterial proliferation even 
though these scaffolds are designed to contain ca. 3 mg/mL of antibiotics, or approximately 
300-fold less concentrated than the established TAP paste at 1 g/mL [15-17, 19]. These 
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unique characteristics may contribute to creating conditions inside the root canal system for 
the subsequent in-growth of a new pulp-like tissue after regenerative endodontic procedures 
(i.e., evoked bleeding) and, at the same time, prevent stem cell toxicity.
In the present research, the exposure of a young biofilm to a relatively novel TAP-mimic 
polymer scaffold exhibited a notable elimination of cultivable bacteria similar to the 
saturated TAP solution. The SEM images of the TAP-mimic scaffold revealed that non-
viable bacteria adhered to the dentin surface even after being killed by the antibiotics. This 
probably occurred because PDS scaffolds may have an attractive potential that makes 
removal of the dead bacteria difficult [19]. On the other hand, SEM images of the saturated 
TAP solution group demonstrated the formation of calcium-enriched insoluble agglomerates 
over the dentin surface, agreeing with previous research studies [19,33]. The antimicrobial 
effects of both triple and double antibiotic pastes against E. faecalis and P. gingivalis 
biofilms have been previously demonstrated [31,34]; however, no study has investigated the 
effects of a TAP-mimic scaffold on P. gingivalis-infected dentin biofilm. Thus far, only one 
study used the proposed TAP-mimic scaffold against Actinomyces naeslundii-infected 
dentin biofilm, proving significant bacteria elimination through CLSM [19]. Taken together, 
both previous and current findings reveal that the proposed, low-concentrated TAP-mimic 
polymer-based scaffold acts not only on monospecies facultative bacteria (A. naeslundii) but 
also on strictly anaerobe bacteria. Worth mentioning, the kinetics of drug release of the TAP-
mimic scaffolds was previously evaluated via high performance liquid chromatography 
(HPLC). It was demonstrated a sustained maintenance of MET and CIP was observed over 4 
weeks, but not for MINO [19]. Therefore, considering the drug release profile of the 
proposed TAP-mimic PDS-based electrospun scaffold, MET and MINO might have the most 
antimicrobial effects against P. gingivalis. Future studies using strictly anaerobe bacteria, 
including P. gingivalis are deemed necessary to confirm through CLSM its antimicrobial 
efficacy deep into the dentinal tubules. Moreover, multispecies biofilms developed on dentin 
surfaces should also be tested to provide further insight regarding the antimicrobial action of 
this scaffold prior to its clinical use.
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Figure 1. 
The number of P. gingivalis cells in biofilm on exposed dentin in CFU/mL (log10). TAP 
solution and TAP-mimic groups significantly reduced bacterial numbers compared to the 
control and pure PDS. Bacterial numbers of a group with different letters differs statistically 
from other groups (p<.05). There was no difference between TAP solution and TAP-mimic.
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Figure 2. 
Representative SEM images (×2500 and ×5000 magnifications) of 7-day P. gingivalis 
biofilm formation, both on the dentin surface and inside the dentinal tubules (A-H). Infected 
dentin treated with pure PDS demonstrates bacteria inside dentinal tubules and on the dentin 
surface (C-D). TAP-mimic scaffold (E-F) and TAP solution (G-H) images demonstrate dead 
cells on the dentin surface.
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Figure 3. 
High magnification SEM images comparing intact (A), damaged (B), and (C) calcified cells 
found in the different groups, according to the external cell morphology.
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